Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

RegeneRx says Phase 2 trial met primary outcome measure
Yahoo/Fly on the Wall
Monday, June 24, 2013 - 10:42am
tags:
RegeneRx, RGN-137, epidermolysis bullosa
Amarin's Naysayers: Much Ado About Nothing
Seeking Alpha
Monday, June 24, 2013 - 10:40am
tags:
Amarin, Vascepa
Zoetis says fully independent following Pfizer exchange offer
Yahoo/Fly on the Wall
Monday, June 24, 2013 - 10:38am
tags:
Pfizer, Zoetis, animal health
Sanofi Chief Says EU Clinical ‘Data Dump’ to Hurt Drugmakers
Bloomberg
Monday, June 24, 2013 - 10:33am
tags:
Sanofi, Europe, Chris Viehbacher, clinical trials
Bayer rival Boehringer seeks wider use of anti-clotting pill
Reuters
Monday, June 24, 2013 - 10:31am
tags:
Bayer, Boehringer Ingelheim, anticoagulants, Pradaxa, deep vein thrombosis, pulmonary embolism
Teva launches generic Viagra in countries across Europe
The Fly on the Wall
Monday, June 24, 2013 - 10:29am
tags:
generics, Viagra, Teva, Europe
New GSK diabetes drug works, but faces tough competition
Reuters
Monday, June 24, 2013 - 10:28am
tags:
GSK, diabetes, albiglutide, GLP-1 agonist, Victoza, Byetta, Bydureon, Novo Nordisk, Bristol-Myers Squibb, AstraZeneca
Justice Department Sues Sage Pharmaceuticals Inc.
PharmPro
Sunday, June 23, 2013 - 11:40am
tags:
Sage Pharmaceuticals
Is Now a Great Time to Buy Abbott Laboratories Stock?
Motley Fool
Sunday, June 23, 2013 - 11:32am
tags:
Abbott Laboratories
The FDA's Cancer Czar Says He Can't Approve New Drugs Fast Enough
Forbes
Sunday, June 23, 2013 - 11:32am
tags:
FDA
Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
Yahoo/Market Wired
Sunday, June 23, 2013 - 11:30am
tags:
Sanofi, U300, insulin, type 2 diabetes, diabetes
Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
Yahoo/PR NewsWire
Sunday, June 23, 2013 - 11:28am
tags:
lixisenatide, type 2 diabetes, diabetes, Sanofi
FDA OKs Piedmont Pharmceuticals vet drug
bizjournals.com
Sunday, June 23, 2013 - 11:26am
tags:
Piedmont Pharmaceuticals, veterinary
Glaxo Diabetes Drug Shows Gastrointestinal Side Effects
Bloomberg
Sunday, June 23, 2013 - 11:22am
tags:
GSK, albiglutide, diabetes, type 2 diabetes
Phase III data show significant reductions in blood glucose with investigational compound empagliflozin used as monotherapy in adults with type 2 diabetes
Yahoo/PR NewsWire
Sunday, June 23, 2013 - 11:20am
tags:
empagliflozin, type 2 diabetes, diabetes, Boehringer Ingelheim
Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
Yahoo/PR NewsWire
Sunday, June 23, 2013 - 11:19am
tags:
LY2605541, Eli Lilly, insulin, type 1 diabetes, diabetes
Sequenom's Growth Potential Is Under-Appreciated
Seeking Alpha
Sunday, June 23, 2013 - 11:13am
tags:
Sequenom
3 Best-Run Biotech Companies
Motley Fool
Sunday, June 23, 2013 - 11:12am
tags:
Biogen Idec, Alexion, Questcor Pharmaceuticals
This Week in Biotech
Motley Fool
Sunday, June 23, 2013 - 11:11am
tags:
Nektar, NKTR-181, pain management, Novartis, serelaxin, Idenix, IDX20963, hepatitis C, ViroPharma, JNJ, Aragon, ARN-509, prostage cancer
Zafgen Says Obesity Drug Spurs Weight Loss in Study
Bloomberg
Sunday, June 23, 2013 - 11:07am
tags:
Zafgen, obesity, weight loss, beloranib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.